Stock Scorer

Argent BioPharma Limited (H5O0.F)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in AUD. Every figure as a table ›

Revenue Annual

0 2M 4M 6M FY22: 4.7M FY23: 3.4M FY24: 891.1K FY22 FY23 FY24

Gross Profit Annual

0 700K 1.4M 2.1M FY22: 1.8M FY23: 1.5M FY24: 203.7K FY22 FY23 FY24

Operating Income Annual

-21M -14M -7M 0 7M 14M 21M FY22: -20.6M FY23: -19.9M FY24: -16.7M FY22 FY23 FY24

Net Income Annual

-24M -16M -8M 0 8M 16M 24M FY22: -20.8M FY23: -21.1M FY24: -17.5M FY22 FY23 FY24

Cost of Revenue Annual

0 1M 2M 3M FY22: 2.9M FY23: 1.9M FY24: 687.4K FY22 FY23 FY24

Operating Cash Flow Annual

-15M -10M -5M 0 5M 10M 15M FY22: -12.2M FY23: -12M FY24: -14.7M FY22 FY23 FY24

Free Cash Flow Annual

-18M -12M -6M 0 6M 12M 18M FY22: -14.9M FY23: -12.2M FY24: -14.8M FY22 FY23 FY24

Operating cash flow minus capital expenditure.

Not drawn for H5O0.F: Shares Outstanding, EPS. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.